|
|||||
       |
RNA illustration (Research.gov) 5 August 2014. The pharmaceutical company Roche is acquiring Santaris Pharma, a biotechnology company developing therapies targeting ribonucleic acid or RNA that performs vital genetic functions. Roche is expected to pay as much as $450 million for Santaris, based in Hørsholm, Denmark. Santaris designs therapies focusing on RNA, a fundamental . . . → Read More: Roche Acquiring RNA Medications Biotech Company  Comments are closed  Finance  biomedical, biotechnology, clinical trials, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals (Research.gov) 4 August 2014. A coalition of research institutes and universities working in neuroscience are constructing a common format for sharing data about the brain to make emerging databases more useful to researchers. The Neurodata Without Borders project is an initiative of Allen Institute for Brain Science, California Institute of Technology, New York . . . → Read More: Consortium to Develop Common Neuroscience Data Format Comments are closed Joint ventures/collaborations biomedical, computer science, engineering, life sciences, NIH, physical sciences, software, standard, university (Bristol-Myers Squibb) 4 August 2014. Allied Minds, a research commercialization company in Boston, and the pharmaceutical company Bristol-Myers Squibb in New York are starting a joint venture to discover new drug candidates and enterprises from promising life science research in U.S. university labs. Financial terms of the new venture, named Allied-Bristol Life Sciences . . . → Read More: Allied Minds, Bristol-Myers Squibb Form Life Science Venture Comments are closed Finance, Joint ventures/collaborations biomedical, entrepreneurs, equity, investment, life sciences, merger, pharmaceuticals, preclinical, university, venture capital (National Institute on Aging, NIH) 1 August 2014. A new challenge on InnoCentive is seeking biomarkers that help predict the effectiveness of pain-killing therapies for patients with neuropathic pain. The challenge requires a detailed written proposal due on 27 September 2014, with a payout of $25,000. Free registration is required to see the . . . → Read More: Challenge Seeks Biomarkers for Neuropathic Pain Jim Kim Montclare (New York University) 1 August 2014. Biochemists at New York University synthesized a protein that removes the toxic elements of chemicals found in pesticides and some chemical warfare agents. The team led by Jin Kim Montclare at NYU’s engineering school published its findings last week in the journal ChemBioChem (paid . . . → Read More: Engineered Protein Detoxes Pesticides, Chemical Weapons Comments are closed New products biomedical, biotechnology, chemistry, engineering, life sciences, mathematics, patent, pharmaceuticals, software, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.